Related Experiment Video
Updated: Oct 10, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction
Anthony P Carnicelli1, Ruth Owen2, Stuart J Pocock3
1Duke University Hospital, Durham, North Carolina, USA.
Insights
Patients with atrial fibrillation (AF) after myocardial infarction (MI) experience poorer quality of life and increased hospitalization risk. Many with AF post-MI remain undertreated with oral anticoagulants, despite high stroke risk.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Atrial fibrillation (AF) and myocardial infarction (MI) frequently coexist and are linked to adverse health outcomes.
- The impact of AF on the quality of life and prognosis for patients following MI is not well understood.
Purpose of the Study:
- To compare the characteristics, quality of life, and clinical outcomes of stable patients post-MI with and without AF.
- To identify potential gaps in the management of oral anticoagulation in patients with AF post-MI.
Main Methods:
- Analysis of data from the prospective, international, observational TIGRIS registry, including 8406 patients 1-3 years post-MI.
- Assessment of quality of life using EQ-5D at baseline and clinical outcomes over 2 years of follow-up.
- Multivariable adjustment to compare outcomes between patients with and without AF.
Main Results:
- AF was present in 8.5% of patients; these patients were older with more comorbidities.
- Patients with AF reported significantly lower quality of life scores (EQ-5D index, VAS, usual activities, pain/discomfort).
- Despite high CHA2DS2-VASc scores, less than half of AF patients were on oral anticoagulants; they experienced higher all-cause hospitalization rates (aRR 1.25) but similar mortality.
Conclusions:
- Stable patients post-MI with AF exhibit poorer quality of life and an elevated risk of clinical events compared to those without AF.
- A significant proportion of patients with AF post-MI are undertreated with oral anticoagulants, indicating a need for improved management strategies.
Objective:
Atrial fibrillation (AF) and myocardial infarction (MI) are commonly comorbid and associated with adverse outcomes. Little is known about the impact of AF on quality of life and outcomes post-MI. We compared characteristics, quality of life and clinical outcomes in stable patients post-MI with/without AF.
Methods/Results:
The prospective, international, observational TIGRIS (long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease) registry included 8406 patients aged ≥50 years with ≥1 atherothrombotic risk factor who were 1-3 years post-MI. Patient characteristics were summarised by history of AF. Quality of life was assessed at baseline using EQ-5D. Clinical outcomes over 2 years of follow-up were compared. History of AF was present in 702/8277 (8.5%) registry patients and incident AF was diagnosed in 244/7575 (3.2%) over 2 years. Those with AF were older and had more comorbidities than those without AF. After multivariable adjustment, patients with AF had lower self-reported quality-of-life scores (EQ-5D UK-weighted index, visual analogue scale, usual activities and pain/discomfort) than those without AF. CHA2DS2-VASc score ≥2 was present in 686/702 (97.7%) patients with AF, although only 348/702 (49.6%) were on oral anticoagulants at enrolment. Patients with AF had higher rates of all-cause hospitalisation (adjusted rate ratio 1.25 [1.06-1.46], p=0.008) over 2 years than those without AF, but similar rates of mortality.
Conclusions:
In stable patients post-MI, those with AF were commonly undertreated with oral anticoagulants, had poorer quality of life and had increased risk of clinical outcomes than those without AF.
Trial Registration Number:
ClinicalTrials: NCT01866904.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure III: Clinical Manifestations
Endocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction

